259 LIBERTY AVENUE, STATEN ISLAND, NY
Annual Report to Security Holders
Material Contracts, Unregistered Sales of Equity Securities, Other Events
Acurx Announces Ibezapolstat Trial for Recurrent CDI Treatment
News, Articles of Incorporation
Shareholder votes
Announces Reverse Stock Split
Announces Exercise of Warrants for $2.67 Million Gross Proceeds
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload